Qube Research & Technologies (QRT)
OPK icon

Qube Research & Technologies (QRT)’s Opko Health OPK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-404,358
Closed -$461K – 3904
2026
Q1 		$461K Buy
404,358
+301,595
+293% +$371K ﹤0.01% 2765
2025
Q4 		$129K Buy
+102,763
New +$143K ﹤0.01% 3144
2024
Q1 		– Sell
-74,259
Closed -$112K – 4760
2023
Q4 		$112K Sell
74,259
-871
-1% -$1.26K ﹤0.01% 3061
2023
Q3 		$120K Buy
+75,130
New +$137K ﹤0.01% 2599
2023
Q1 		– Sell
-210,617
Closed -$263K – 2884
2022
Q4 		$263K Buy
210,617
+180,444
+598% +$284K ﹤0.01% 1697
2022
Q3 		$57K Buy
+30,173
New +$71.3K ﹤0.01% 2108
2021
Q1 		– Sell
-27,338
Closed -$108K – 2274
2020
Q4 		$108K Buy
27,338
+4,355
+19% +$18.2K ﹤0.01% 1638
2020
Q3 		$85K Buy
22,983
+11,311
+97% +$47.7K ﹤0.01% 1507
2020
Q2 		$40K Buy
+11,672
New +$26.1K ﹤0.01% 1623

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OPK Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Opko Health (OPK) in Q2 2026, closing a stake of 404,358 shares — an estimated $461K sold.

Qube Research & Technologies (QRT) first reported a position in OPK in Q2 2020 and held it in 9 quarters. The position peaked at $461K in Q1 2026. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Opko Health position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 404,358 Opko Health shares in Q2 2026, an estimated $461K.
  • Qube Research & Technologies (QRT) first reported a position in Opko Health in Q2 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Opko Health position peaked at $461K in Q1 2026.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.